Kroeger Christopher A.: insider trades.
Kroeger Christopher A. reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($5.4M), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 7
- Companies
- 1
- Name as filed
- Kroeger Christopher A.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | Director, Officer · Chief Executive Officer | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-17 | MapLight Therapeutics, Inc. | A | 23,145 | $0 | 1,269,600 | Form 4 |
| 2026-07-17 | MapLight Therapeutics, Inc. | S | 16,779 | $37.9 | 1,246,455 | Form 4 |
| 2026-07-16 | MapLight Therapeutics, Inc. | S | 28,091 | $37.26 | 1,263,326 | Form 4 |
| 2026-07-16 | MapLight Therapeutics, Inc. | S | 92 | $37.96 | 1,263,234 | Form 4 |
| 2026-07-16 | MapLight Therapeutics, Inc. | S | 40,899 | $36.46 | 1,291,417 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 18,950 | $36 | 1,375,144 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 42,738 | $36.99 | 1,332,406 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 90 | $37.54 | 1,332,316 | Form 4 |
Questions
What stock did Kroeger Christopher A. buy or sell?
Kroeger Christopher A. reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($5.4M), across 1 company.
Is Kroeger Christopher A. the same person as other filers with this name?
This page covers SEC CIK 1658918 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/kroeger-christopher-a-1658918.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.